LifeConEx 6 P's
The Goals of Cold Chain Management
-
Patient safety
-
Product integrity
-
Regulatory compliance
-
Process optimization
-
Cost optimization
Our principles, the 6P's, are our key to achieve the above goals. They shape the way we view cold chain management.
People
It’s all about patient safety…We connect people with life.
As medicines and their ingredients are produced all over the world, the existence of—and adherence to – quality standards is even more critical.
*Source: LifeConEx
Products
Product stability is at the heart of understanding temperature needs.
“The capacity of a drug substance or drug product to remain within specification established to ensure its identity, strength, quality, and purity.”
Throughout a study, a “stability profile” is created, which allows the behavior of substance over time when correctly stored or transported.
*Source: FDA Guidance for Industry: Stability Testing of Drug Substance and Drug Products
FDA Guidance for Industry: Analytical Procedures and Methods Validation
Partners
Everyone is responsible for Good Distribution Practices (GDP).
“It is critical for all partners to collaborate with an important goal in mind: to maintain the balanced solutions with highest standards, because they are the links between the products and the patients.” ~ David Bang, CEO, LifeConEx
*Source: WHO Technical Report Series 937 Annex 5
Processes
Proper design and qualification reduce the risk toward shipment failure and ensure product delivery, efficacy, and safety.
-
Process design
-
Process qualification
-
Continued process verification
*Source: FDA U.S. Food and Drug Administration
Packaging
Select the best packaging for your product:
-
Active versus passive
-
Size and shape
-
Payload
-
Thermal test profile
-
Test equipment calibration
-
Position and type of refrigerant
-
Package equilibration period
*Source: PDA PCCIG EU Branch Lead, Berlin PDA 2010
Places
Understand the shipping lane:
-
Assess the risks of origin and destination
-
Infrastructure
-
Duration
-
Customs process
-
Regulatory guidelines
*Source: PDA PCCIG EU Branch Lead, Berlin PDA 2010
